IRF7 controls spontaneous autoimmune germinal center and plasma cell checkpoints
Authors:
- Adam J. FikeAFAdam J. Fike
- Kristen N. BrickerKBKristen N. Bricker
- Michael V. GonzalezMGMichael V. Gonzalez
- Anju MaharjanAMAnju Maharjan
- Tien BuiTBTien Bui
- Keomonyroth NuonKNKeomonyroth Nuon
- Scott M. EmrichSEScott M. Emrich
- Julia L. WeberJWJulia L. Weber
- Sara A. LuckenbillSLSara A. Luckenbill
- Nicholas M. ChoiNCNicholas M. Choi
- Renan SauteraudRSRenan Sauteraud
- Dajiang J. LiuDLDajiang J. Liu
- 29 May 2025
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (7)
Abstract
How IRF7 promotes autoimmune B cell responses and systemic autoimmunity is unclear. Analysis of spontaneous SLE-prone mice deficient in IRF7 uncovered the IRF7 role in regulating autoimmune germinal center (GC), plasma cell (PC), and autoantibody responses and disease. IRF7, however, was dispensable for foreign antigen–driven GC, PC, and antibody responses. Competitive bone marrow (BM) chimeras highlighted the importance of IRF7 in hematopoietic cells in spontaneous GC and PC differentiation. Single-cell RNAseq of SLE-prone B cells indicated IRF7-mediated B cell differentiation through GC and PC fates. Mechanistic studies revealed that IRF7 promoted B cell differentiation through GC and PC fates by regulating the transcriptome, translation, and metabolism of SLE-prone B cells. Mixed BM chimeras demonstrated a requirement for B cell–intrinsic IRF7 in IgG autoantibody production but not in the regulation of spontaneous GC and PC responses. Altogether, we delineate previously unknown B cell–intrinsic and –extrinsic mechanisms of IRF7-promoted spontaneous GC and PC responses, loss of tolerance, autoantibody production, and SLE development.Keywords
All Related Versions
Funding Information
- National Institutes of Health (RO1 AI162971)
- PennState College of Medicine
- American Association of Immunology
- National Cancer Institute (5T32CA060395-25)
- Lupus Foundation of America
- National Heart, Lung, and Blood Institute (R35 HL150778)
- Pennsylvania Department of Health
This publication has 50 references indexed in Scilit:
- Pathogenesis of kidney disease in systemic lupus erythematosusCurrent Opinion in Rheumatology, 2009
- Control of Toll-like Receptor 7 Expression Is Essential to Restrict Autoimmunity and Dendritic Cell ProliferationImmunity, 2007
- Murine Dendritic Cell Type I IFN Production Induced by Human IgG-RNA Immune Complexes Is IFN Regulatory Factor (IRF)5 and IRF7 Dependent and Is Required for IL-6 ProductionThe Journal of Immunology, 2007
- Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptorsSeminars in Immunology, 2007
- Toll-like Receptor 7 and TLR9 Dictate Autoantibody Specificity and Have Opposing Inflammatory and Regulatory Roles in a Murine Model of LupusImmunity, 2006
- Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosusJournal of Clinical Investigation, 2005
- IRF-7 is the master regulator of type-I interferon-dependent immune responsesNature, 2005
- Evolution of Autoantibody Responses via Somatic Hypermutation Outside of Germinal CentersScience, 2002
- Genetic Modifiers of Systemic Lupus Erythematosus in FcγRIIB−/− MiceJournal of Experimental Medicine, 2002
- The Roles of B Cells in MRL/lpr Murine LupusAnnals of the New York Academy of Sciences, 1997